Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Clinical trial NCT07039110 · RECRUITING
Trial details
- NCT number
- NCT07039110
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-09
- Primary completion
- 2028-03-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.